glp 1 in heart failure GLP-1 receptor agonists and myocardial metabolism atrial fibrillation SGLTi and GLP-1 in HF

The Good: Weight loss starts within 2-4 weeks for most people Clinical trials show 10-22.5% average weight loss over 12-18 months Some people achieve up to 40% weight loss Blood pressure and blood sugar improvements Reduced food noise (those constant thoughts about eating) The Reality Check: About 1 in 10 people dont lose any weight at all (non-responders) Nausea in the first few weeks (manageable with proper guidance) Occasional diarrhoea or constipation Injection site reactions Rare but serious risks like pancreatitis requiring immediate medical attention Heres something most places wont tell you: these arent magic bullets

This information, interpreted by a qualified provider, can support more informed conversation about which GLP-1 formulation may align with your biological profile

Additionally, the hormone suppresses appetite by telling your body it is full faster and for more extended periods of time to avoid eating too often and too much

These studies clearly showed that the simultaneous activation of GIP and GLP1 receptors was anti-obesogenic and could be utilized for its therapeutic potential

And if you have any questions I did before I took my first shot they were answered promptly